Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 1 / Phase 22025-07-14NCT03971799

3 results · Page 1 of 1

Swipe the table sideways for more columns.

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's Hospital of ColoradoAuroraUnited States28
Children's Hospital of Los AngelesLos AngelesUnited States56
Dana-Farber Cancer InstituteBostonUnited States626
National Cancer Institute - NIHBethesdaUnited States1
Seattle Children's Hospital/Fred Hutchinson Cancer Research CenterSeattleUnited States1
The Children's Hospital of PhiladelphiaPhiladelphiaUnited States62